| 10/29/2026 3:52 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/20/2026 6:40 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/29/2026 7:19 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/21/2026 7:55 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/14/2026 6:20 PM | Smith Darren Charlton (2122447) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 7:30 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/31/2026 7:39 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/19/2026 8:48 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/21/2026 6:06 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/18/2026 5:31 PM | Rivas Maria (1755794) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/18/2026 5:33 PM | Jellison William R (1189883) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for TLPPF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/18/2026 5:34 PM | GILL DAVID N (1106519) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 8:32 PM | Behrenbruch Christian (2037713) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 6:49 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/21/2026 3:05 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 3:28 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 8:30 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 5:02 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/13/2026 3:01 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/09/2026 8:26 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/08/2026 8:23 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/07/2026 5:27 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 6:14 PM | Smith Darren Charlton (2122447) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 6:25 AM | Smith Darren Charlton (2122447) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 6:25 AM | Cade David Norman (2123007) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 6:24 AM | Patti Darren Joel (2122492) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 6:24 AM | Nelson Mark Alexander (1352919) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/20/2026 3:06 PM | Telix Pharmaceuticals (2007191) Filer | Form 20-F/A | |
| 03/18/2026 7:45 PM | Behrenbruch Christian (2037713) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:47 PM | Skinner Jann Elizabeth (2121838) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:48 PM | McDonald Marie Elizabeth (2120369) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/16/2026 4:00 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/20/2026 5:09 AM | Telix Pharmaceuticals (2007191) Filer | Form F-3ASR | |
| 02/19/2026 7:44 PM | Telix Pharmaceuticals (2007191) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/19/2026 4:22 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/18/2026 8:12 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/02/2026 7:50 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/20/2026 3:15 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 3:07 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 5:52 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/17/2025 3:06 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Trump’s EO to send this $5 stock ripping higher…? (Ad) President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations.
One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars.
Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading. Get the full free report on this overlooked space stock now |
| 12/08/2025 3:08 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |